Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference
- The company to mark new phase of growth at Bio Campus II with the opening of Plant 5 in April - Samsung Biologics to offer ADC services and invest in advanced development and manufacturing capabilities to better address clients' needs INCHEON, South Korea, Jan. 15, 2025 /PRNewswire/ -- Samsung Biologics (KRX:...
QNET’s BELITE 123: Your Trusted Partner in Sustainable Health and Weight Management
HONG KONG, Jan. 15, 2025 /PRNewswire/ -- With the start of a new year, many of us set ambitious goals to improve our health and manage our weight. While resolutions often fade, QNET's LifeQode BELITE 123 stands as a proven, reliable companion on the journey to sustainable health. A well-established product trusted by thousands worldwide, BELITE 123 offers a holistic...
Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65, a Differentiated CLDN6-Targeting ADC, Powered by AxcynDOT™ Technology
AT03-65 is the first program utilizing AxcynDOT™, a proprietary payload with a differentiated mechanism of action, to enter clinical development SINGAPORE, Jan. 15, 2025 /PRNewswire/ -- Axcynsis Therapeutics Pte Ltd ("Axcynsis"), a privately held biopharmaceutical company specialized in delivering Antibody Drug Conjugates (ADCs) with breakthrough potential, proudly announces the clearance of its...
Stämm’s Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots
Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar flow bioreactor: the Bioprocessor. SAN FRANCISCO, Jan. 15, 2025 /PRNewswire/ -- Stämm unveiled breakthrough results of its continuous bioreactor for monoclonal antibody production with pilot studies in...
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
NEW YORK, Jan. 15, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company"), a leading provider of OTC pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the pricing of its initial public offering (the "Offering") of an aggregate of 1,403,685 ordinary shares of par value $0.001 per share (the...
South Korea’s WIRobotics Takes the Spotlight at CES 2025, Plans Global Expansion
YONGIN, South Korea, Jan. 15, 2025 /PRNewswire/ -- WIRobotics, the company behind the revolutionary wearable mobility solution WIM(We Innovate Mobility), has achieved a major milestone at CES 2025, one of the world's premier technology trade shows. Featuring more than 4,500 companies from 166 countries showcasing cutting-edge innovations, the event set a new...
TraceLink Wins 2024 Merit Award for Technology in HealthTech Category for Second Consecutive Year
BOSTON, Jan. 15, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, is proud to announce its recognition as a winner of the 2024 Merit Awards for Technology in the HealthTech category. This marks the second consecutive year that TraceLink has been honored...
Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales
Michael Irwin will drive Metabolon's global sales strategy as the company moves into its next phase of growth in the mutliomic marketplace MORRISVILLE, N.C., Jan. 14, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine...
IMG Marks a Milestone: Celebrating 35 Years of Global Peace of Mind
INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to celebrate its 35th anniversary of providing travel and health safety solutions to travelers. "For three and a half decades, IMG has proudly served millions of members around the world with...
Endogenex™ Appoints Krissy Wright as Chief Financial Officer
Bringing finance, operational, and corporate development expertise to an experienced leadership team. MINNEAPOLIS, Jan. 15, 2025 /PRNewswire/ -- Endogenex, Inc., a clinical-stage medical device company, is proud to announce the addition of Krissy Wright as Chief Financial Officer (CFO). In this role, Wright will lead Endogenex's financial strategy, corporate development initiatives, and operational...
